Recent research focusing on Semaglutide at a dosage of 40mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may boost the drug's ability to manage blood levels, potentially offering greater outcomes for individuals with type 2 diabetes. Further study is underway to fully understand the long-term